Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.34% Nasdaq Up0.16%

Myriad Genetics Inc. (MYGN)

-NMS

33.01 Down 0.05(0.15%) May 21, 4:00PM EDT|After Hours : 33.20 Up 0.19 (0.58%) May 21, 7:08PM EDT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Net Income 37,893   35,036   30,136   29,142  
Operating Activities, Cash Flows Provided By or Used In
Depreciation2,180  2,244  2,211  2,328  
Adjustments To Net Income12,257  15,980  15,020  10,418  
Changes In Accounts Receivables(27,182)(19,609)(8,570)(17,918)
Changes In Liabilities8,133  (11,869)12,390  18,593  
Changes In Inventories3,331  135  972  (1,246)
Changes In Other Operating Activities784  197  (803)428  
Total Cash Flow From Operating Activities 37,396   22,114   51,356   41,745  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(1,574)(4,547)(2,461)(2,192)
Investments49,655  (29,490)(2,544)2,018  
Other Cash flows from Investing Activities -   -   -  (8,000)
Total Cash Flows From Investing Activities 48,081   (34,037) (5,005) (8,174)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock(43,219)(18,397)(37,583)(54,025)
Net Borrowings -   -   -   -  
Other Cash Flows from Financing Activities -   -   -   -  
Total Cash Flows From Financing Activities (41,577) (15,237) (37,120) (52,029)
Effect Of Exchange Rate Changes -   -   -  (42)
Change In Cash and Cash Equivalents 43,900   (27,160) 9,231   (18,500)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.